Randomized clinical trials (RCTs) have long been recognized as the gold standard for testing the safety and efficacy of pharmaceutical interventions. Despite their rigorous methodology, RCTs are not without limitations – logistical demands, recruitment hurdles, elevated costs, selection bias, inability to detect rare and long-term adverse effects, and limited generalizability Read more…
Polygon Health Analytics will present two research projects on Systemic Lupus Erythematosus (SLE), through collaboration with Temple University and the University of Florida at ACR 2023 in San Diego on Tuesday, November 14. An Electronic Health Record-Based Algorithm for Predicting Systemic Lupus Erythematosus Flares: Integrating Clinical Factors and Social Determinants Read more…
Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely used to evaluate a treatment’s real-world effectiveness, safety, and economic value, but it has also been increasingly leveraged in clinical trials. To promote the progression this field, FDA has published Read more…
Large Language Models (LLMs), including ChatGPT, have gained significant traction since late 2022, sparking debates about whether they’re mere hype or a genuine revolution. However, their undeniable utility spans personal and business activities, including but not limited to proofreading and editing, language translation, coding and debugging, and content creation. At Read more…